Polymer Drugs in the Clinical Stage Advantages and Prospects /
Autor Corporativo: | SpringerLink (Online service) |
---|---|
Otros Autores: | Maeda, Hiroshi. (Editor ), Kabanov, Alexander. (Editor ), Kataoka, Kazunori. (Editor ), Okano, Teruo. (Editor ) |
Formato: | eBook |
Lenguaje: | English |
Publicado: |
New York, NY :
Springer US : Imprint: Springer,
2003.
|
Edición: | 1st ed. 2003. |
Colección: | Advances in Experimental Medicine and Biology,
519 |
Materias: | |
Acceso en línea: | https://doi.org/10.1007/b105364 |
Ejemplares similares
-
Inhibitors of Protein Kinases and Protein Phosphates /
Publicado: (2005) -
Interpretation and Extrapolation of Chemical and Biological Carcinogenicity Data to Establish Human Safety Standards The Use of Short-Term Tests for Mutagenicity and Carcinogenicity in Chemical Hazard Evaluation /
Publicado: (1984) -
Mouse Liver Tumors Relevance to Human Cancer Risk Symposium of the European Society ofToxicology Held in Rome, February 2–5, 1986 /
Publicado: (1987) -
The Selection of Doses in Chronic Toxicity/Carcinogenicity Studies Age-Associated (Geriatric) Pathology: Its Impact on Long-Term Toxicity Studies /
Publicado: (1984) -
New Approaches to Drug Discovery /
Publicado: (2016)